These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27677409)

  • 1. ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism.
    Tian Z; Miyata K; Kadomatsu T; Horiguchi H; Fukushima H; Tohyama S; Ujihara Y; Okumura T; Yamaguchi S; Zhao J; Endo M; Morinaga J; Sato M; Sugizaki T; Zhu S; Terada K; Sakaguchi H; Komohara Y; Takeya M; Takeda N; Araki K; Manabe I; Fukuda K; Otsu K; Wada J; Murohara T; Mohri S; Yamashita JK; Sano M; Oike Y
    Nat Commun; 2016 Sep; 7():13016. PubMed ID: 27677409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating ANGPTL2 Levels Increase in Humans and Mice Exhibiting Cardiac Dysfunction.
    Tian Z; Miyata K; Morinaga J; Horiguchi H; Kadomatsu T; Endo M; Zhao J; Zhu S; Sugizaki T; Sato M; Terada K; Okumura T; Murohara T; Oike Y
    Circ J; 2018 Jan; 82(2):437-447. PubMed ID: 28890470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANGPTL2　- A New Causal Player in Accelerating Heart Disease Development in the Aging.
    Oike Y; Tian Z; Miyata K; Morinaga J; Endo M; Kadomatsu T
    Circ J; 2017 Sep; 81(10):1379-1385. PubMed ID: 28867689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction.
    Trivieri MG; Oudit GY; Sah R; Kerfant BG; Sun H; Gramolini AO; Pan Y; Wickenden AD; Croteau W; Morreale de Escobar G; Pekhletski R; St Germain D; Maclennan DH; Backx PH
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):6043-8. PubMed ID: 16595628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of ANGPTL2 promotes left ventricular systolic dysfunction by upregulation of NOX4 in mice.
    Labbé P; Martel C; Shi YF; Montezano A; He Y; Gillis MA; Higgins MÈ; Villeneuve L; Touyz R; Tardif JC; Thorin-Trescases N; Thorin E
    Front Physiol; 2024; 15():1320065. PubMed ID: 38426206
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress.
    Aoi J; Endo M; Kadomatsu T; Miyata K; Ogata A; Horiguchi H; Odagiri H; Masuda T; Fukushima S; Jinnin M; Hirakawa S; Sawa T; Akaike T; Ihn H; Oike Y
    Mol Cancer Res; 2014 Feb; 12(2):239-49. PubMed ID: 24258150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholamban degradation is induced by phosphorylation-mediated ubiquitination and inhibited by interaction with cardiac type Sarco(endo)plasmic reticulum Ca(2+)-ATPase.
    Nakagawa T; Yokoe S; Asahi M
    Biochem Biophys Res Commun; 2016 Apr; 472(3):523-30. PubMed ID: 26966065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury.
    Tian Z; Miyata K; Tazume H; Sakaguchi H; Kadomatsu T; Horio E; Takahashi O; Komohara Y; Araki K; Hirata Y; Tabata M; Takanashi S; Takeya M; Hao H; Shimabukuro M; Sata M; Kawasuji M; Oike Y
    J Mol Cell Cardiol; 2013 Apr; 57():1-12. PubMed ID: 23333801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
    Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
    Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
    Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
    Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy.
    Belke DD; Gloss B; Swanson EA; Dillmann WH
    Endocrinology; 2007 Jun; 148(6):2870-7. PubMed ID: 17317766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA).
    Stammers AN; Susser SE; Hamm NC; Hlynsky MW; Kimber DE; Kehler DS; Duhamel TA
    Can J Physiol Pharmacol; 2015 Oct; 93(10):843-54. PubMed ID: 25730320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling.
    Daniels A; van Bilsen M; Janssen BJ; Brouns AE; Cleutjens JP; Roemen TH; Schaart G; van der Velden J; van der Vusse GJ; van Nieuwenhoven FA
    Acta Physiol (Oxf); 2010 Sep; 200(1):11-22. PubMed ID: 20175764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis.
    Wei J; Xu H; Shi L; Tong J; Zhang J
    Chem Biol Interact; 2015 Jul; 236():47-56. PubMed ID: 25937560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
    Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
    Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.